Reviewing Semler Scientific (NASDAQ:SMLR) and Movano (NASDAQ:MOVE)

Semler Scientific (NASDAQ:SMLR) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Profitability

This table compares Semler Scientific and Movano’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Semler Scientific	25.62%	21.17%	19.40%
Movano	N/A	-452.96%	-233.43%

Valuation & Earnings

This table compares Semler Scientific and Movano’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semler Scientific	$68.18 million	2.42	$20.58 million	$2.79	8.47
Movano	$852,000.00	35.87	-$29.28 million	($0.56)	-0.56

Semler Scientific has higher revenue and earnings than Movano. Movano is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 16.6% of Movano shares are owned by institutional investors. 13.0% of Semler Scientific shares are owned by company insiders. Comparatively, 13.4% of Movano shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Semler Scientific has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Semler Scientific and Movano, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0	0	0	1	4.00
Movano	0	0	1	0	3.00

Movano has a consensus target price of $2.00, indicating a potential upside of 543.09%. Given Movano’s higher probable upside, analysts plainly believe Movano is more favorable than Semler Scientific.

Summary

Semler Scientific beats Movano on 11 of the 15 factors compared between the two stocks.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

About Movano

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.